Leaflet PALEXIA 20mg / ml oral solution


Indicated for: moderate to severe pain

Route of administration: oral

Substance: tapentadol (opioid analgesic)

ATC: N02AX06 (Nervous system | Opioids | Other opioids)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse
Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression
Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol
Avoid alcohol

Avoid alcohol during treatment.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Seizure risk
Seizure risk

This medicine may increase the risk of seizures.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Tapentadol is an opioid analgesic used for the treatment of moderate to severe pain. It works by activating opioid receptors and inhibiting norepinephrine reuptake, providing effective pain relief.

The medication is taken orally, as directed by a doctor, usually at regular intervals. It is important for patients to follow the prescribed dosage to avoid the risk of dependence or overdose.

Patients should be aware of potential side effects, such as drowsiness, dizziness, or nausea. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, dizziness, nausea, and constipation. In rare cases, severe reactions such as respiratory depression or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about PALEXIA 20mg / ml

  • Substance: tapentadol
  • Date of last drug list: 01-04-2026
  • Commercial code: W59482001
  • Concentration: 20mg / ml
  • Pharmaceutical form: oral solution
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: TAB2 - Medicines that are issued with a special prescription (narcotics) in yellow color.

Concentrations available for tapentadol

  • 100mg
  • 150mg
  • 200mg
  • 20mg/ml
  • 250mg
  • 25mg
  • 4mg/ml
  • 50mg
  • 75mg